Foundation Medicine
Foundation Medicine Q2 FY16: revenue $28.2M
- Form
- 10-Q/A
- Filed
- Period
- Importance
- Routine
- Accession
- 0001564590-16-029389
- Document
- 10-Q/A
- Exhibit 10.5
- Material contract
Key figures from this report
These are the numbers Foundation Medicine reported for Q2 FY16, the quarter ended Jun 30, 2016, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$28.2MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Net income−$29.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$62.3MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
Similar companies
Same SIC code (8071) and public float not reported.
- BillionToOne BLLN
- Burning Rock Biotech BNR
- Halberd HALB
- Lumexa Imaging Holdings LMRI
- MDxHealth MDXH
